Primary Site >> Pancreatic Cancer

Gene >> TNF

  • 1985
  • 1988
  • 1989
  • 1990
  • 1991
  • 1992
  • 1993
  • 1994
  • 1995
  • 1996
  • 1997
  • 1998
  • 1999
  • 2000
  • 2001
  • 2002
  • 2003
  • 2004
  • 2005
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: [Antitumor effect of the tumor necrosis factor against various types of human cancer cells].
PMID: 4062318
Ref: Antiproliferative effects exerted by recombinant human tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on human pancreatic tumor cell lines.
PMID: 3131759
Ref: [Low sensitivity of choriocarcinoma cell lines to tumor necrosis factor (TNF)-alpha].
PMID: 2504846
Ref: [Clinical efficacy of intratumoral administration of BRM in advanced cancer and their mechanism of actions].
PMID: 2782888
Ref: Binding and biological effects of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells.
PMID: 2111548
Ref: Upregulation of interferon-gamma binding by tumor necrosis factor and lymphotoxin: disparate potencies of the cytokines and modulation of their effects by phorbol ester.
PMID: 1903142
Ref: Modulation of platelet-derived growth factor A- and B-chain/c-sis mRNA by tumor necrosis factor and other agents in adenocarcinoma cells.
PMID: 1906154
Ref: [Effect of lipid A on the production of tumor necrosis factor (TNF) and antitumor activity against pancreatic cancer cells: preliminary report].
PMID: 1508144
Ref: Activity of a recombinant transforming growth factor-alpha-Pseudomonas exotoxin hybrid protein against primary human tumor colony-forming units.
PMID: 1607249
Ref: Importance of E-selectin (ELAM-1) and sialyl Lewis(a) in the adhesion of pancreatic carcinoma cells to activated endothelium.
PMID: 7687590
Ref: De novo expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in pancreas cancer.
PMID: 8093883
Ref: Inverse regulation of human ERBB2 and epidermal growth factor receptors by tumor necrosis factor alpha.
PMID: 8105469
Ref: Anti-proliferative effect of combined tumour necrosis factor-alpha and interferon-alpha on human pancreatic cancer in vitro and in vivo.
PMID: 8239528
Ref: Tumor necrosis factor alpha induces the expression of transforming growth factor alpha and the epidermal growth factor receptor in human pancreatic cancer cells.
PMID: 8430098
Ref: The expression and biological activity of IL-2 receptor on a human pancreas cancer cell line.
PMID: 8507543
Ref: The MHC class-II and CD44 molecules are involved in the induction of tumour necrosis factor (TNF) gene expression by human monocytes stimulated with tumour cells.
PMID: 7508890
Ref: Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer.
PMID: 7512810
Ref: [Molecular mechanism in hematogenous metastasis of pancreas carcinoma--possible implication of tumor-derived cytokine in a cell-to-cell interaction of pancreas carcinoma and vascular endothelial cells].
PMID: 7525435
Ref: Lymphokine-activated killer cytotoxicity against pancreas adenocarcinoma cell lines and vascular endothelial cells.
PMID: 7804431
Ref: Response of adenosquamous carcinoma of the pancreas to interferon-alpha, tumor necrosis factor-alpha and 5-fluorouracil combined treatment.
PMID: 7872711
Ref: Recombinant human tumor necrosis factor causes regression in patients with advanced malignancies.
PMID: 8208522
Ref: E-selectin expression induced by pancreas-carcinoma-derived interleukin-1 alpha results in enhanced adhesion of pancreas-carcinoma cells to endothelial cells.
PMID: 7532161
Ref: Characterization of a novel human tumor necrosis factor-alpha mutant with increased cytotoxic activity.
PMID: 7737913
Ref: Characterization of tumor-necrosis-factor-gene-transduced tumor-infiltrating lymphocytes from ascitic fluid of cancer patients: analysis of cytolytic activity, growth rate, adhesion molecule expression and cytokine production.
PMID: 7882388
Ref: Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC.
PMID: 8528743
Ref: Effects of a new synthetic lipid A on endogenous tumor necrosis factor production and antitumor activity against human pancreatic cancer cells.
PMID: 8830332
Ref: Augmented antitumor effects of killer cells induced by tumor necrosis factor gene-transduced autologous tumor cells from gastrointestinal cancer patients.
PMID: 8894681
Ref: Endogenous tumor necrosis factor inhibits the cytotoxicity of exogenous tumor necrosis factor and adriamycin in pancreatic carcinoma cells.
PMID: 8899800
Ref: Differentiation of pancreatic ductal carcinoma cells associated with selective expression of protein kinase C isoforms.
PMID: 8915489
Ref: Elevated serum interleukin-6 and decreased thyroid hormone levels in postoperative patients and effects of IL-6 on thyroid cell function in vitro.
PMID: 9001195
Ref: Synthetic lipid A produces antitumor effect in a hamster pancreatic carcinoma model through production of tumor necrosis factor from activated macrophages.
PMID: 9023454
Ref: Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer.
PMID: 9164211
Ref: Biliary interleukin-6 and tumor necrosis factor-alpha in patients undergoing endoscopic retrograde cholangiopancreatography.
PMID: 9201097
Ref: [Newly-developing therapies of pancreatic cancer--immunotherapy, gene therapy, differentiation therapy, endocrine therapy and others].
PMID: 9276872
Ref: Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity in pancreatic carcinoma cells via enhancement of the heart shock element-binding activity of heart shock factor 1.
PMID: 9395854
Ref: TNF-alpha induction of A1 expression in human cancer cells.
PMID: 9563010
Ref: [The inhibitory effect of combined treatment of TNF alpha and antisense oligodeoxynucleotides on the growth of human pancreatic carcinoma cell line cells].
PMID: 10374336
Ref: Experimental study of the effect of IL-6 on cancer cachexia.
PMID: 21590167
Ref: Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
PMID: 9485028
Ref: Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response.
PMID: 9488524
Ref: An apoptosis-inducing gene therapy for pancreatic cancer with a combination of 55-kDa tumor necrosis factor (TNF) receptor gene transfection and mutein TNF administration.
PMID: 9563482
Ref: The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB.
PMID: 9781666
Ref: Inhibitory effects of streptozotocin, tumor necrosis factor-alpha, and interleukin-1beta on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase.
PMID: 9989930
Ref: Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells.
PMID: 10210643
Ref: Neopterin serum levels in pancreatic adenocarcinoma.
PMID: 10211419
Ref: Human PACAP response gene 1 (p22/PRG1): proliferation-associated expression in pancreatic carcinoma cells.
PMID: 10231843
Ref: Hollow-spheres: a new model for analyses of differentiation of pancreatic duct epithelial cells.
PMID: 10415853
Ref: Growth factors and cytokines in pancreatic carcinogenesis.
PMID: 10415856
Ref: Ubiquitin-proteasome inhibition enhances apoptosis of human pancreatic cancer cells.
PMID: 10455908
Ref: Two polymorphisms of the tumour necrosis factor gene do not influence survival in pancreatic cancer.
PMID: 10469042
Ref: Tumor size and lymph-node status in pancreatic carcinoma - is there a correlation to the preoperative immune function?
PMID: 10552294
Ref: C-met protooncogene expression and its regulation by cytokines in the regenerating pancreas and in pancreatic cancer cells.
PMID: 10672841
Ref: Transforming growth factor-beta1 acts as a potent inhibitor of complement C3 biosynthesis in human pancreatic cancer cell lines.
PMID: 10707928
Ref: Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells.
PMID: 10760829
Ref: Enhanced expression of Silencer of death domains (SODD/BAG-4) in pancreatic cancer.
PMID: 10799310
Ref: The expression of chemokine genes correlates with nuclear factor-kappaB activation in human pancreatic cancer cell lines.
PMID: 10881930
Ref: Dynamics of diurnal changes in serum concentration of TNF-alpha soluble receptors in gastrointestinal cancer patients.
PMID: 11037054
Ref: Dynamics of circadian fluctuations in serum concentration of cortisol and TNF-alpha soluble receptors in gastrointestinal cancer patients.
PMID: 11115600
Ref: Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines.
PMID: 11169257
Ref: Loss of skeletal muscle in cancer: biochemical mechanisms.
PMID: 11171557
Ref: Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients.
PMID: 11396212
Ref: The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines.
PMID: 11513873
Ref: Augmented adriamycin sensitivity in cells transduced with an antisense tumor necrosis factor gene is mediated by caspase-3 downstream from reactive oxygen species.
PMID: 11572767
Ref: Antioxidants inhibit cytokine production and suppress NF-kappaB activation in CAPAN-1 and CAPAN-2 cell lines.
PMID: 11768272
Ref: PI-3' kinase and NF-kappaB cross-signaling in human pancreatic cancer cells.
PMID: 12086898
Ref: The role of oxygen-derived free radicals and nitric oxide in cytokine-induced antiproliferation of pancreatic cancer cells.
PMID: 11854621
Ref: Laparoscopic gatrojejunostomy for palliation of gastric outlet obstruction in unresectable gastric cancer.
PMID: 12073005
Ref: Large-scale expansion of CD3(+)CD56(+) lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants.
PMID: 12202905
Ref: Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer.
PMID: 12239630
Ref: Resection of pancreatic cancer normalizes the preoperative increase of tumor necrosis factor alpha gene expression.
PMID: 12378118
Ref: Endogenous tumor necrosis factor promotes resistance to cellular stresses by inducing the metallothionein-1A gene.
PMID: 12553033
Ref: Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis.
PMID: 12490654
Ref: Experimental studies of serum cytokine concentration following pancreatic electrolytic ablation.
PMID: 12552236
Ref: Site-dependent angiogenic cytokine production in human tumor xenografts.
PMID: 12670449
Ref: Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis.
PMID: 12712434
Ref: Circadian fluctuations of melatonin, tumor necrosis factor-alpha and its soluble receptors in the circulation of patients with advanced gastrointestinal cancer.
PMID: 12866566
Ref: Diverse responses between human pancreatic cancer cell lines to native alpha 1-antitrypsin and its C-terminal fragment.
PMID: 12894502
Ref: Analysis of tumour necrosis factor alpha and interleukin 10 promotor variants in patients with chronic pancreatitis.
PMID: 14560157
Ref: The lack of a systemic inflammatory response syndrome supports the safety of pancreatic electrolysis: experimental studies.
PMID: 14732357
Ref: A bispecific antibody to enhance radiotherapy by tumor necrosis factor-alpha in human CEA-expressing digestive tumors.
PMID: 14751531
Ref: Prevention and reversal of tumor cell-induced monocyte deactivation by cytokines, purified protein derivative (PPD), and anti-IL-10 antibody.
PMID: 15327279
Ref: [A case report of metastatic pancreatic cancer that responded remarkably to the combination of thalidomide, celecoxib and irinotecan].
PMID: 15446566
Ref: Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis.
PMID: 15454338
Ref: [The repetitive immune cell transfer therapy combining non-myelosuppressive chemotherapy for patients with advanced and refractory cancer].
PMID: 15553672
Ref: [Study on acute pancreatitis-associated lung injury induced by L-arginine in mice].
PMID: 15573769
Ref: Combined therapy of experimental pancreatic cancer with CYP2B1 producing cells: low-dose ifosfamide and local tumor irradiation.
PMID: 15455374
Ref: Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial.
PMID: 15753541
Ref: Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
PMID: 15781649
Ref: Enhancement of the caspase-independent apoptotic sensitivity of pancreatic cancer cells by DHMEQ, an NF-kappaB inhibitor.
PMID: 16211219
Ref: Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome.
PMID: 16314628
Ref: Insulinotropic and anti-inflammatory effects of rosiglitazone in experimental autoimmune diabetes.
PMID: 17491689
Ref: Beneficial effect of resveratrol on cholecystokinin-induced experimental pancreatitis.
PMID: 16499907
Ref: Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase.
PMID: 16552574
Ref: Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
PMID: 16614115
Ref: The expression of adhesion molecules and the influence of inflammatory cytokines on the adhesion of human pancreatic carcinoma cells to mesothelial monolayers.
PMID: 16670622
Ref: Clinical monitoring of innate cellular immunity of monocytes/macrophages by tumor necrosis factor alpha productivity in whole blood stimulated by lipopolysaccharide in patients with pancreatic cancer.
PMID: 16804410
Ref: Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma.
PMID: 16982746
Ref: Impact of interferon-alpha in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI): first data from the immunomonitoring.
PMID: 17198089
Ref: Systemic immune dysfunction in pancreatic cancer patients.
PMID: 17235586
Ref: G2/M cell-cycle arrest and apoptosis by n-3 fatty acids in a pancreatic cancer model.
PMID: 17291531
Ref: Effects of thalidomide in experimental models of post-endoscopic retrograde cholangiopancreatography pancreatitis.
PMID: 17295769
Ref: Leukemia inhibitory factor functions as a growth factor in pancreas carcinoma cells: Involvement of regulation of LIF and its receptor expression.
PMID: 17332938
Ref: Synthetic serine protease inhibitor, gabexate mesilate, prevents nuclear factor-kappaB activation and increases TNF-alpha-mediated apoptosis in human pancreatic cancer cells.
PMID: 17357832
Ref: Induction of interleukin-8 (CXCL-8) by tumor necrosis factor-alpha and leukemia inhibitory factor in pancreatic carcinoma cells: Impact of CXCL-8 as an autocrine growth factor.
PMID: 17671691
Ref: Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.
PMID: 17762760
Ref: The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines.
PMID: 18082672
Ref: Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.
PMID: 18316608
Ref: Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes.
PMID: 18383873
Ref: Period is involved in the proliferation of human pancreatic MIA-PaCa2 cancer cells by TNF-alpha.
PMID: 18480551
Ref: Claudin-1 expression is induced by tumor necrosis factor-alpha in human pancreatic cancer cells.
PMID: 18949385
Ref: [Molecular mechanisms and its clinical impact in cancer cachexia].
PMID: 19053008
Ref: Characterization of sonic hedgehog as a novel NF-kappaB target gene that promotes NF-kappaB-mediated apoptosis resistance and tumor growth in vivo.
PMID: 18772349
Ref: Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy.
PMID: 18974777
Ref: AMT: preclinical pharmacology studies.
PMID: 19360346
Ref: Interleukin-32 expression in the pancreas.
PMID: 19386602
Ref: Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.
PMID: 19405118
Ref: Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy.
PMID: 19405981
Ref: Translation of the radio- and chemo-inducible TNFerade vector to the treatment of human cancers.
PMID: 19444302
Ref: Combination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer.
PMID: 19444305
Ref: CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNF-alpha.
PMID: 19577543
Ref: Surgical resection after TNFerade therapy for locally advanced pancreatic cancer.
PMID: 19734632
Ref: Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells.
PMID: 19768141
Ref: Blood monocytes stimulate migration of human pancreatic carcinoma cells in vitro: the role of tumour necrosis factor - alpha.
PMID: 19782426
Ref: Effects of conjugated linoleic acid on myogenic and inflammatory responses in a human primary muscle and tumor coculture model.
PMID: 19838943
Ref: Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma.
PMID: 20196789
Ref: Effects of carbon monoxide releasing molecule-liberated CO on severe acute pancreatitis in rats.
PMID: 19900821
Ref: Potential carcinogenic effects of cigarette smoke and Swedish moist snuff on pancreas: a study using a transgenic mouse model of chronic pancreatitis.
PMID: 20065943
Ref: Ad.Egr-TNF and local ionizing radiation suppress metastases by interferon-beta-dependent activation of antigen-specific CD8+ T cells.
PMID: 20197756
Ref: Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis.
PMID: 20331621
Ref: NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells.
PMID: 20350779
Ref: Protective effect of cyclosporin A on brain injury in rats with acute necrotic pancreatitis.
PMID: 20561905
Ref: Digestive Disease Week 2010. Turning Science into Medicine--part 2.
PMID: 20582861
Ref: Effects of Qingyi Huaji decoction on serum levels of interleukin-6, interleukin-8 and tumor necrosis factor-alpha in nude mice bearing pancreatic tumors.
PMID: 20619142
Ref: Nuclear expression of interleukin-33 in pancreatic stellate cells.
PMID: 20689058
Ref: Examination of apoptosis signaling in pancreatic cancer by computational signal transduction analysis.
PMID: 20808857
Ref: Association between EGF, TGF-{beta}1, TNF-{alpha} gene polymorphisms and cancer of the pancreatic head.
PMID: 21187523
Ref: PP2A inhibitors induce apoptosis in pancreatic cancer cell line PANC-1 through persistent phosphorylation of IKKalpha and sustained activation of the NF-kappaB pathway.
PMID: 21376459
Ref: Altered expression of genes in adipose tissues associated with reduced fat mass in patients with pancreatic cancer.
PMID: 21457003
Ref: Combination treatment using adenovirus vector-mediated tumor necrosis factor-alpha gene transfer and a NF-kappaB inhibitor for pancreatic cancer in mice.
PMID: 21482023
Ref: Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study.
PMID: 21547597
Ref: Involvement of COX-2/PGE(2) Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer.
PMID: 21760774
Ref: Mesothelin confers pancreatic cancer cell resistance to TNF-alpha-induced apoptosis through Akt/PI3K/NF-kappaB activation and IL-6/Mcl-1 overexpression.
PMID: 21880146
Ref: Induction of monocyte antitumor response by human cancer cells transduced with TNF-GFP fusion gene: possible implications for immunotherapy of cancer.
PMID: 22038233
Ref: Crosstalk between the canonical NF-kappaB and Notch signaling pathways inhibits Ppargamma expression and promotes pancreatic cancer progression in mice.
PMID: 22056382
Ref: Zyflamend sensitizes tumor cells to TRAIL-induced apoptosis through up-regulation of death receptors and down-regulation of survival proteins: role of ROS-dependent CCAAT/enhancer-binding protein-homologous protein pathway.
PMID: 22004570
Ref: Accumulation of pro-cancer cytokines in the plasma fraction of stored packed red cells.
PMID: 22246854
Ref: EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study.
PMID: 22248601
Ref: Effects on apoptosis and cell cycle arrest contribute to the antitumor responses of interleukin-27 mediated by retrovirus in human pancreatic carcinoma cells.
PMID: 22293948
Ref: Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-alpha and TSGF after cryosurgery in pancreatic cancer patients.
PMID: 22456901
Ref: [Protective effects and possible mechanism of lipoxin A(4) analogue in rats with acute pancreatitis].
PMID: 22781577
Ref: New tools and novel approaches in treating locally advanced pancreatic adenocarcinoma.
PMID: 22797388
Ref: Effect of high-dose intravenous vitamin C on inflammation in cancer patients.
PMID: 22963460
Ref: Protective effects of alpha-pinene in mice with cerulein-induced acute pancreatitis.
PMID: 22982349
Ref: Single nucleotide polymorphisms of genes for EGF, TGF-beta and TNF-alpha in patients with pancreatic carcinoma.
PMID: 22990108
Ref: In vitro cytokine profiles and viability of different human cells treated with whole cell lysate of Mycobacterium avium subsp. paratuberculosis.
PMID: 23006537
Ref: The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses.
PMID: 23086953
Ref: Desensitization of NFkappaB for overcoming chemoresistance of pancreatic cancer cells to TNF-alpha or paclitaxel.
PMID: 23155247
Ref: The role of mesothelin in tumor progression and targeted therapy.
PMID: 22721387
Ref: Detection of Legionella pneumophila serogroup 1 in blood cultures from a patient treated with tumor necrosis factor-alpha inhibitor.
PMID: 22911089
Ref: Inhibition of nuclear factor kappa-B enhances the antitumor effect of combination treatment with tumor necrosis factor-alpha gene therapy and gemcitabine for pancreatic cancer in mice.
PMID: 23219147
Ref: Microenvironment generated during EGFR targeted killing of pancreatic tumor cells by ATC inhibits myeloid-derived suppressor cells through COX2 and PGE2 dependent pathway.
PMID: 23394575
Ref: Disrupting cytokine signaling in pancreatic cancer: a phase I/II study of etanercept in combination with gemcitabine in patients with advanced disease.
PMID: 23429495
Ref: Targeting the NF-kappaB and mTOR pathways with a quinoxaline urea analog that inhibits IKKbeta for pancreas cancer therapy.
PMID: 23444213
Ref: Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts.
PMID: 23462920
Ref: Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer.
PMID: 23590467
Ref: Sann-Joong-Kuey-Jian-Tang decreases the protein expression of Mcl1 and TCTP and increases that of TNF-alpha and Bax in BxPC3 pancreatic carcinoma cells.
PMID: 23652631
Ref: Role of Peroxisome Proliferator-Activated Receptor beta/delta and B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells.
PMID: 23737761
Ref: Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-kappaB and MMPs.
PMID: 23918941
Ref: Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer.
PMID: 23940742
Ref: Proteome variations in pancreatic stellate cells upon stimulation with proinflammatory factors.
PMID: 24089530
Ref: Tumor necrosis factor induces tumor promoting and anti-tumoral effects on pancreatic cancer via TNFR1.
PMID: 24098720
Ref: Digitoflavone inhibits IkappaBalpha kinase and enhances apoptosis induced by TNFalpha through downregulation of expression of nuclear factor kappaB-regulated gene products in human pancreatic cancer cells.
PMID: 24146961
Ref: Novel mechanism of cytokine-induced disruption of epithelial barriers: Janus kinase and protein kinase D-dependent downregulation of junction protein expression.
PMID: 24665409
Ref: Depression, cytokines, and pancreatic cancer.
PMID: 24136882
Ref: Apigenin potentiates the growth inhibitory effects by IKK-beta-mediated NF-kappaB activation in pancreatic cancer cells.
PMID: 24148603
Ref: Could signal transducer and activator of transcription 3 be a therapeutic target in obesity-related gastrointestinal malignancy?
PMID: 24163144
Ref: Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-alpha gene therapy for pancreatic cancer.
PMID: 24289533
Ref: Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.
PMID: 24471499
Ref: The multifunctional growth factor midkine promotes proliferation and migration in pancreatic cancer.
PMID: 24567526
Ref: Contribution of environment and genetics to pancreatic cancer susceptibility.
PMID: 24651674
Ref: Induction of Split Anergy Conditions Natural Killer Cells to Promote Differentiation of Stem Cells through Cell-Cell Contact and Secreted Factors.
PMID: 24995006
Ref: Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition.
PMID: 25072100
Ref: Genetic polymorphisms of inflammatory response gene TNF-alpha and its influence on sporadic pancreatic neuroendocrine tumors predisposition risk.
PMID: 25213764
Ref: Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction.
PMID: 25274283
Ref: Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203.
PMID: 25290620
Ref: [Pancreas and biliary tract: recent developments].
PMID: 25294273
Ref: Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot study.
PMID: 25408239
Ref: Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreatic cancer.
PMID: 25411961
Ref: Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-alpha signaling in the pancreas of rats on a high-fat diet.
PMID: 25453543
Ref: Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer.
PMID: 25344906
Ref: Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions.
PMID: 25361845
Ref: 5-Lipoxygenase and cyclooxygenase inhibitory dammarane triterpenoid 1 from Borassus flabellifer seed coat inhibits tumor necrosis factor-alpha secretion in LPSInduced THP-1 human monocytes and induces apoptosis in MIA PaCa-2 pancreatic cancer cells.
PMID: 25642980
Ref: Measuring sickness behavior in the context of pancreatic cancer.
PMID: 25659492
Ref: Suppressive effects of exogenous regucalcin on the proliferation of human pancreatic cancer MIA PaCa-2 cells in vitro.
PMID: 25847529
Ref: Orthotopic inflammation-related pancreatic carcinogenesis in a wild-type mouse induced by combined application of caerulein and dimethylbenzanthracene.
PMID: 25916208
Ref: CD4(+) T cells potently induce epithelial-mesenchymal-transition in premalignant and malignant pancreatic ductal epithelial cells-novel implications of CD4(+) T cells in pancreatic cancer development.
PMID: 26137395
Ref: Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics.
PMID: 26310895
Ref: A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer.
PMID: 26314849
Ref: Acetylshikonin Inhibits Human Pancreatic PANC-1 Cancer Cell Proliferation by Suppressing the NF-kappaB Activity.
PMID: 26336582
Ref: Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer.
PMID: 26343824
Ref: Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression.
PMID: 26479921
Ref: Augmented IFN-gamma and TNF-alpha Induced by Probiotic Bacteria in NK Cells Mediate Differentiation of Stem-Like Tumors Leading to Inhibition of Tumor Growth and Reduction in Inflammatory Cytokine Release; Regulation by IL-10.
PMID: 26697005
Ref: Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
PMID: 26413860
Ref: Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer.
PMID: 26597191
Ref: Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
PMID: 26849077
Ref: AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas.
PMID: 26884209
Ref: Expression of tumor necrosis factor-alpha-induced protein 8 in stage III gastric cancer and the correlation with DcR3 and ERK1/2.
PMID: 26998086
Ref: Thymoquinone Modulates Blood Coagulation in Vitro via Its Effects on Inflammatory and Coagulation Pathways.
PMID: 27043539
Ref: Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution.
PMID: 27133426
Ref: Irradiated human endothelial progenitor cells induce bystander killing in human non-small cell lung and pancreatic cancer cells.
PMID: 27258472
Ref: Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.
PMID: 27267809
Ref: Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells.
PMID: 27573419
Ref: Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.
PMID: 27835602
Ref: Hyperglycemia, tumorigenesis, and chronic inflammation.
PMID: 27931833
Ref: Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors.
PMID: 27864344
Ref: A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients.
PMID: 28111717
Ref: Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer in vitro.
PMID: 28223726
Ref: Effect of cigarette smoke exposure and mutant Kras overexpression on pancreatic cell proliferation.
PMID: 28454347
Ref: The long non-coding RNA HOTAIR enhances pancreatic cancer resistance to TNF-related apoptosis-inducing ligand.
PMID: 28476883
Ref: Mucin 1, a signal transduction membrane-bound mucin, is present in human disc tissue and is downregulated in vitro by exposure to IL-1ss or TNF-alpha.
PMID: 28482827
Ref: miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity.
PMID: 28511795
Ref: Anticancer activity of salicin and fenofibrate.
PMID: 28733879
Ref: NF-kappaB regulates GDF-15 to suppress macrophage surveillance during early tumor development.
PMID: 28891811
Ref: SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects.
PMID: 28958848
Ref: CXCR5(+) CD8(+) T cells potently infiltrate pancreatic tumors and present high functionality.
PMID: 28965867
Ref: Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients.
PMID: 29037917
Ref: Postoperative course and prognostic value of circulating angiogenic cytokines after pancreatic cancer resection.
PMID: 29069789
Ref: The Diagnostic Roles of Cytokines in Hepatobiliary Cancers.
PMID: 29410961
Ref: GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells.
PMID: 29092903
Ref: The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC).
PMID: 29313457
Ref: The Warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells.
PMID: 29609556
Ref: Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses.
PMID: 29618658
Ref: Transforming Growth Factor-beta and Tumor Necrosis Factor-alpha Reduce the Sensitivity of MiaPaCa2 Pancreatic Cancer Cells to Lysis by NK Cells.
PMID: 29926278
Ref: Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer.
PMID: 30011858
Ref: Human Surfactant Protein D Suppresses Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells by Downregulating TGF-beta.
PMID: 30158928
Ref: Liver metastasis of pancreatic cancer: the hepatic microenvironment impacts differentiation and self-renewal capacity of pancreatic ductal epithelial cells.
PMID: 30167093
Ref: Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma.
PMID: 30167864
Ref: Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness.
PMID: 30185628